Detalhe da pesquisa
1.
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention.
BMC Geriatr;
22(1): 191, 2022 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35272615
2.
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility.
Vaccines (Basel);
10(3)2022 Mar 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35335078
3.
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.
AIDS;
18(2): 227-35, 2004 Jan 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15075540
4.
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001.
J Acquir Immune Defic Syndr;
36(2): 761-4, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15167299